Global Rib Fracture Repair Systems demand is anticipated to be valued at US$ 420.3 Million in 2022, forecast to grow at a CAGR of 5.2% to be valued at US$ 699.5 Million from 2022 to 2032. Growth is attributed to the human vulnerability to rib fractures and injuries.
Report Attribute | Details |
---|---|
Estimated Base Year Value (2021) | US$ 400.0 Million |
Expected Market Value (2022) | US$ 420.3 Million |
Anticipated Forecast Value (2032) | US$ 699.5 Million |
Projected Growth Rate (2022 to 2032) | 5.2% CAGR |
Rib Fracture Repair Systems are implants and devices, that are designed to support the reconstruction of a fractured rib. The devices are primarily made up of titanium alloys and stainless steel coated by the polymer. The novel type of core internal fixation implants and devices will escalate the growth opportunities for the rib fracture repair system market.
Rib Fracture Repair Systems is one of the prime comprehensive thoracic care systems. The repair system integrates locking screws and plates. The plates offer an advantage in intraoperative bleeding offering surgeons an advantage for surgery.
Other major factors like the human vulnerability to rib fractures and injuries, and an unbalanced food diet, coupled with the increase in the geriatric population are likely to boost the market growth during the forecast period.
On the flip side, the stringent regulatory guidelines for the approval of new treatments are further projected to impede the growth of the rib fracture treatment market in the timeline period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The increasing number of hard falls, accidental cases, domestic issues, and other types of violence are the major factors that are expected to fuel the growth of the Rib Fracture Repair Systems market over the forecast period.
The rise in cases of low bone density and the growing amount of excessive playing of contact sports including football and rugby are further anticipated to accelerate the growth of the rib fracture treatment market in the forthcoming years.
The human vulnerability to rib fractures and injuries, and an unbalanced food diet, coupled with the increase in the geriatric population are the major factors that are likely to boost the market growth during the forecast period.
Factors such as the rising cases of osteoporosis and arthritis, the rise in the healthcare infrastructure, and the growth of the aging population due to the natural phenomenon of aging leading to fragile bone structures are expected to augment the market growth over the analysis period.
Factors such as the high rate of invasion associated with Rib Fracture Repair Systems and long surgical procedures are expected to hinder the growth of the Rib Fracture Repair Systems market during the forecast period.
Unsuitable reimbursement policies, and the increased expenses of surgeries, and therapy are the major factors that are anticipated to impede market growth in the near future.
The stringent regulatory guidelines for the approval of new treatments are further projected to hamper the growth of the rib fracture treatment market over the analysis period.
North America dominates the rib fracture treatment market, attributed to the high demand for rib fracture treatment for treating trauma cases and sports-related injuries. In addition, the growing healthcare infrastructure is further expected to propel the growth of the rib fracture treatment market in the region over the analysis period.
The increasing number of casualties from motor accidents is one of the major factors that is anticipated to augment the market growth in the region in the forthcoming years.
The Rib Fracture Repair Systems market in North America is expected to hold the largest share of US$ 330.3 Million. Considering the revenue generation, the regional market is expected to reach a CAGR of 5.15% during the forecast period.
The Asia-Pacific rib fracture repair systems market is expected to reach a CAGR of 4.6% with a market value of US$ 250.9 Million. The rib fracture repair systems market in Asia-Pacific is expected to observe a significant amount of growth in the rib fracture treatment market during the forecast period, attributed to the growing incidence of rib fracture cases in the region.
The constant rise in the population in Asia Pacific countries including China and India is one of the major factors that is anticipated to boost the regional growth of rib fracture repair systems over the analysis period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key participants present in the global Rib Fracture Repair Systems market include DePuy Synthes, SIG Medical, Zimmer Biomet, Acumed, LLC, Novartis AG, Sun Pharmaceutical Industries Ltd., Larken Laboratories, Teva Pharmaceutical Industries Ltd., Cipher Pharmaceuticals Inc., Mylan N.V., Purdue Pharma L.P., Allergan plc., USWM, LLC., GlaxoSmithKline plc., and Pfizer Inc., among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as DePuy Synthes, SIG Medical, Zimmer Biomet, Acumed, LLC, and Novartis AG, account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in North America.
Recent Developments:
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 5.2% from 2022 to 2032 |
Market Value in 2022 | US$ 420.3 Million |
Market Value in 2032 | US$ 699.5 Million |
Base Year for Estimation | 2021 |
Historical Data | 2017 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered |
|
Regional Scope |
|
Country Scope |
|
Key Companies Profiled |
|
Report Customization & Pricing | Available upon Request |
FMI projects the global Rib Fracture Repair Systems market to expand at a 5.2% value CAGR by 2032
North America is expected to be the most opportunistic Rib Fracture Repair Systems market, expanding at 5.15% CAGR
DePuy Synthes, SIG Medical, Zimmer Biomet, Acumed, LLC, Novartis AG, Sun Pharmaceutical Industries Ltd., Larken Laboratories, and Teva Pharmaceutical Industries Ltd., are some prominent Rib Fracture Repair Systems manufacturers
1. Executive Summary | Rib Fracture Repair Systems Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032 5.3.1. U Plate Rib Fracture Repair Systems 5.3.2. Anterior Plate Rib Fracture Repair Systems 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Hospitals 6.3.2. Ambulatory Surgical Centers 6.3.3. Specialty Clinics 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. United Kingdom 8.2.1.2. Canada 8.2.2. By Product Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Product Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By End User 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Malaysia 11.2.1.5. Singapore 11.2.1.6. Australia 11.2.1.7. Rest of Asia Pacific 11.2.2. By Product Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By End User 11.4. Key Takeaways 12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of Middle East and Africa 12.2.2. By Product Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By End User 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. United Kingdom 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Product Type 13.1.2.2. By End User 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Product Type 13.2.2.2. By End User 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Product Type 13.3.2.2. By End User 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Product Type 13.4.2.2. By End User 13.5. Rest of Latin America 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Product Type 13.5.2.2. By End User 13.6. Germany 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Product Type 13.6.2.2. By End User 13.7. United Kingdom 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Product Type 13.7.2.2. By End User 13.8. France 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Product Type 13.8.2.2. By End User 13.9. Spain 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Product Type 13.9.2.2. By End User 13.10. Italy 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Product Type 13.10.2.2. By End User 13.11. Rest of Europe 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Product Type 13.11.2.2. By End User 13.12. China 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Product Type 13.12.2.2. By End User 13.13. Japan 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Product Type 13.13.2.2. By End User 13.14. South Korea 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Product Type 13.14.2.2. By End User 13.15. Malaysia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Product Type 13.15.2.2. By End User 13.16. Singapore 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Product Type 13.16.2.2. By End User 13.17. Australia 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2021 13.17.2.1. By Product Type 13.17.2.2. By End User 13.18. Rest of Asia Pacific 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2021 13.18.2.1. By Product Type 13.18.2.2. By End User 13.19. GCC Countries 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2021 13.19.2.1. By Product Type 13.19.2.2. By End User 13.20. South Africa 13.20.1. Pricing Analysis 13.20.2. Market Share Analysis, 2021 13.20.2.1. By Product Type 13.20.2.2. By End User 13.21. Israel 13.21.1. Pricing Analysis 13.21.2. Market Share Analysis, 2021 13.21.2.1. By Product Type 13.21.2.2. By End User 13.22. Rest of the Middle East and Africa 13.22.1. Pricing Analysis 13.22.2. Market Share Analysis, 2021 13.22.2.1. By Product Type 13.22.2.2. By End User 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Product Type 14.3.3. By End User 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Johnson & Johnson Services, Inc. 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.2. SIG Medical 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.3. Zimmer Biomet 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.4. Acumed, LLC 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.5. Jeil Medical Corporation 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.6. Waston Medical Co., Ltd. 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.7. NEURO FRANCE Implants 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.8. KLS Martin Group 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.9. Stryker Corporation 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.10. Olympus Corporation 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports